ornithylaspartate has been researched along with urea in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gladisch, R; Hagmüller, E; Holm, E; Kortsik, C; Leweling, H; Staedt, U | 1 |
Beckers, G; Gaunitz, F; Gebhardt, R; Haupt, W; Jonitza, D; Klein, S; Scheja, L | 1 |
Butterworth, RF; Kircheis, G; Michalak, A; Pannunzio, P; Quack, G; Rose, C; Therrien, G | 1 |
CIMINO, F; CITTADINI, D; DAYELLO CARACCIOLO, M; SALVATORE, F | 1 |
Blanco Vela, CI; Poo RamÃrez, JL | 1 |
1 trial(s) available for ornithylaspartate and urea
Article | Year |
---|---|
Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design.
Topics: Adult; Amino Acids; Ammonia; Blood Glucose; Dipeptides; Double-Blind Method; Female; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Urea | 1993 |
4 other study(ies) available for ornithylaspartate and urea
Article | Year |
---|---|
Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels.
Topics: Amino Acids; Ammonia; Animals; Carbon Tetrachloride; Dipeptides; Liver; Liver Cirrhosis, Experimental; Rats; Urea | 1997 |
L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.
Topics: Ammonia; Animals; Dipeptides; Glutamic Acid; Hepatic Encephalopathy; Male; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Urea | 1998 |
MECHANISM OF THE PROTECTION BY L-ORNITHINE-L-ASPARTATE MIXTURE AND BY L-ARGININE IN AMMONIA INTOXICATION.
Topics: Ammonia; Arginine; Aspartic Acid; Chemical and Drug Induced Liver Injury; Dipeptides; Hepatitis; Ligases; Metabolism; Ornithine; Pharmacology; Rats; Research; Toxicology; Urea | 1964 |
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
Topics: Administration, Oral; Ammonia; Dipeptides; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Quality of Life; Severity of Illness Index; Treatment Outcome; Urea | 2011 |